These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 25656049)
21. Proteomic profiling reveals KRT6C as a probable hereterodimer partner for KRT9: New insights into re-classifying epidermolytic palmoplantar keratoderma (EPPK) and a milder form of pachyonychia congenita (PC-K6c) as a group of genetic cutaneous disorders. Li P; Qi J; Zhong Y; Ding A; Xiao H J Proteomics; 2023 Sep; 287():104971. PubMed ID: 37467889 [TBL] [Abstract][Full Text] [Related]
22. EGFR Signaling Is Overactive in Pachyonychia Congenita: Effective Treatment with Oral Erlotinib. Basset J; Marchal L; Hovnanian A J Invest Dermatol; 2023 Feb; 143(2):294-304.e8. PubMed ID: 36116508 [TBL] [Abstract][Full Text] [Related]
23. Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16. Spaunhurst KM; Hogendorf AM; Smith FJ; Lingala B; Schwartz ME; Cywinska-Bernas A; Zeman KJ; Tang JY Br J Dermatol; 2012 Apr; 166(4):875-8. PubMed ID: 22098151 [TBL] [Abstract][Full Text] [Related]
24. A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Smith FJ; Jonkman MF; van Goor H; Coleman CM; Covello SP; Uitto J; McLean WH Hum Mol Genet; 1998 Jul; 7(7):1143-8. PubMed ID: 9618173 [TBL] [Abstract][Full Text] [Related]
25. Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders. Lessard JC; Coulombe PA J Invest Dermatol; 2012 May; 132(5):1384-91. PubMed ID: 22336941 [TBL] [Abstract][Full Text] [Related]
26. Novel proline substitution mutations in keratin 16 in two cases of pachyonychia congenita type 1. Smith FJ; Del Monaco M; Steijlen PM; Munro CS; Morvay M; Coleman CM; Rietveld FJ; Uitto J; McLean WH Br J Dermatol; 1999 Dec; 141(6):1010-6. PubMed ID: 10606845 [TBL] [Abstract][Full Text] [Related]
30. Development of therapeutic siRNAs for pachyonychia congenita. Smith FJ; Hickerson RP; Sayers JM; Reeves RE; Contag CH; Leake D; Kaspar RL; McLean WH J Invest Dermatol; 2008 Jan; 128(1):50-8. PubMed ID: 17762855 [TBL] [Abstract][Full Text] [Related]
31. Can skin disease cause neuropathic pain? A study in pachyonychia congenita. Wallis T; Poole CD; Hoggart B Clin Exp Dermatol; 2016 Jan; 41(1):26-33. PubMed ID: 26358843 [TBL] [Abstract][Full Text] [Related]
32. A novel missense mutation L468Q of keratin 6a in pachyonychia congenita type 1. Zhou HL; Yang S; Gao M; Zhao XY; Zhu YG; Li W; Ren YQ; Liang YH; Du WH; Zhang XJ J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):351-5. PubMed ID: 17309457 [TBL] [Abstract][Full Text] [Related]
33. Clinical and pathological features of pachyonychia congenita. Leachman SA; Kaspar RL; Fleckman P; Florell SR; Smith FJ; McLean WH; Lunny DP; Milstone LM; van Steensel MA; Munro CS; O'Toole EA; Celebi JT; Kansky A; Lane EB J Investig Dermatol Symp Proc; 2005 Oct; 10(1):3-17. PubMed ID: 16250204 [TBL] [Abstract][Full Text] [Related]
34. Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment. Zieman AG; Coulombe PA Br J Dermatol; 2020 Mar; 182(3):564-573. PubMed ID: 31021398 [TBL] [Abstract][Full Text] [Related]
35. Keratin gene mutations in disorders of human skin and its appendages. Chamcheu JC; Siddiqui IA; Syed DN; Adhami VM; Liovic M; Mukhtar H Arch Biochem Biophys; 2011 Apr; 508(2):123-37. PubMed ID: 21176769 [TBL] [Abstract][Full Text] [Related]
36. Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation. Abdollahimajd F; Rajabi F; Shahidi-Dadras M; Saket S; Youssefian L; Vahidnezhad H; Uitto J Br J Dermatol; 2019 Sep; 181(3):584-586. PubMed ID: 30307612 [TBL] [Abstract][Full Text] [Related]
38. Insights into genotype-phenotype correlation in pachyonychia congenita from the human intermediate filament mutation database. McLean WH; Smith FJ; Cassidy AJ J Investig Dermatol Symp Proc; 2005 Oct; 10(1):31-6. PubMed ID: 16250207 [TBL] [Abstract][Full Text] [Related]
39. Genotype-phenotype correlations of neurovascular structures on the feet in patients with pachyonychia congenita: A cross-sectional study. Tan XL; Thomas BR; Steele L; Schwartz J; Hansen CD; O'Toole EA J Am Acad Dermatol; 2022 Nov; 87(5):1172-1174. PubMed ID: 35245567 [No Abstract] [Full Text] [Related]
40. Peripheral neuropathic changes in pachyonychia congenita. Pan B; Byrnes K; Schwartz M; Hansen CD; Campbell CM; Krupiczojc M; Caterina MJ; Polydefkis M Pain; 2016 Dec; 157(12):2843-2853. PubMed ID: 27776012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]